✦ LIBER ✦

A Novel Conjugated Agent between Dopamine and an A 2A Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach

✍ Scribed by Dalpiaz, Alessandro; Cacciari, Barbara; Vicentini, Chiara Beatrice; Bortolotti, Fabrizio; Spalluto, Giampiero; Federico, Stephanie; Pavan, Barbara; Vincenzi, Fabrizio; Borea, Pier Andrea; Varani, Katia

Book ID: 120312562
Publisher: American Chemical Society
Year: 2012
Tongue: English
Weight: 906 KB
Volume: 9
Category: Article
ISSN: 1543-8384
DOI: 10.1021/mp200489d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Adenosine A2a Recep

ChemInform Abstract: Adenosine A2a Receptor Antagonists as Novel anti-Parkinsonian Agents: A Review of Structure—Activity Relationships

✍ F. Azam; I. A. Ibn-Rajab; A. A. Alruiad 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 16 KB 👁 2 views

An antagonistic interaction between A2B

An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells

✍ Silvia V. Conde; Constancio Gonzalez; Joana R. Batuca; Emilia C. Monteiro; Ana O 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

The broad-spectrum anti-emetic activity

The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist

✍ Takashi Yoshikawa; Naoyuki Yoshida; Makoto Oka 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 208 KB

Combined Target-Based and Ligand-Based D

Combined Target-Based and Ligand-Based Drug Design Approach as a Tool To Define a Novel 3D-Pharmacophore Model of Human A 3 Adenosine Receptor Antagonists: Pyrazolo[4,3- e ]1,2,4-triazolo[1,5- c ]pyrimidine Derivatives as a Key Study

✍ Moro, Stefano; Braiuca, Paolo; Deflorian, Francesca; Ferrari, Cristina; Pastorin 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 294 KB

An alternative approach to developing do

An alternative approach to developing dopamine-receptor agonists with central presynaptic actions following oral administration: A comparison between apomorphine, bromocriptine, and the novel compound RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane)

✍ Stephen P. Arnerić; Dr. John P. Long 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 712 KB

Arneric, S. P., and J. P. Long: An alternative approach to developing dopamine-receptor agonists with central presynaptic actions following oral administration: A comparison between apomorphine, bromocriptine, and the novel compound RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane). Drug. Dev. Res. 3